List of Excipients in API roflumilast
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing roflumilast
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | DALIRESP | roflumilast | 0310-0095 | LACTOSE MONOHYDRATE | |
| AstraZeneca Pharmaceuticals LP | DALIRESP | roflumilast | 0310-0095 | MAGNESIUM STEARATE | |
| AstraZeneca Pharmaceuticals LP | DALIRESP | roflumilast | 0310-0095 | POVIDONE | |
| AstraZeneca Pharmaceuticals LP | DALIRESP | roflumilast | 0310-0095 | STARCH, CORN | |
| Arcutis Biotherapeutics Inc | ZORYVE | roflumilast | 80610-130 | CETEARETH-10 PHOSPHATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing roflumilast
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 | CELLULOSE, MICROCRYSTALLINE |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 | CROSCARMELLOSE SODIUM |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 | HYDROXYPROPYL CELLULOSE |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 | LACTOSE MONOHYDRATE |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 | MAGNESIUM STEARATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for roflumilast
Excipient focus: BUTANE
roflumilast drug variants containing BUTANE
| Company | Ingredient | NDC |
|---|---|---|
| Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing BUTANE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE CALCIUM
roflumilast drug variants containing CARBOXYMETHYLCELLULOSE CALCIUM
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing CARBOXYMETHYLCELLULOSE CALCIUM
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Camber Pharmaceuticals Inc | roflumilast | 31722-623 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
roflumilast drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| Zydus Pharmaceuticals USA Inc | roflumilast | 68382-969 |
| Zydus Lifesciences Limited | roflumilast | 70771-1674 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| Camber Pharmaceuticals Inc | roflumilast | 31722-623 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETEARETH-10 PHOSPHATE
roflumilast drug variants containing CETEARETH-10 PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
| Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing CETEARETH-10 PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETEARYL PHOSPHATE
roflumilast drug variants containing CETEARYL PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
| Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing CETEARYL PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETOSTEARYL ALCOHOL
roflumilast drug variants containing CETOSTEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
| Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing CETOSTEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
roflumilast drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Solco Healthcare US LLC | roflumilast | 43547-005 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
roflumilast drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| Camber Pharmaceuticals Inc | roflumilast | 31722-623 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIETHYLENE GLYCOL MONOETHYL ETHER
roflumilast drug variants containing DIETHYLENE GLYCOL MONOETHYL ETHER
| Company | Ingredient | NDC |
|---|---|---|
| Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
| Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing DIETHYLENE GLYCOL MONOETHYL ETHER
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: HEXYLENE GLYCOL
roflumilast drug variants containing HEXYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
| Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing HEXYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
roflumilast drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
| Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
roflumilast drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| Micro Labs Limited | roflumilast | 42571-259 |
| Solco Healthcare US LLC | roflumilast | 43547-005 |
| Strides Pharma Science Limited | roflumilast | 64380-786 |
| Bryant Ranch Prepack | roflumilast | 72162-2385 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| Camber Pharmaceuticals Inc | roflumilast | 31722-623 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
roflumilast drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | roflumilast | 68382-969 |
| Zydus Lifesciences Limited | roflumilast | 70771-1674 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
roflumilast drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply Inc | roflumilast | 51407-975 |
| Aurobindo Pharma Limited | roflumilast | 59651-275 |
| Aurobindo Pharma Limited | roflumilast | 59651-801 |
| Ascend Laboratories LLC | roflumilast | 67877-480 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOBUTANE
roflumilast drug variants containing ISOBUTANE
| Company | Ingredient | NDC |
|---|---|---|
| Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing ISOBUTANE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL PALMITATE
roflumilast drug variants containing ISOPROPYL PALMITATE
| Company | Ingredient | NDC |
|---|---|---|
| Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
| Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing ISOPROPYL PALMITATE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
roflumilast drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | roflumilast | 31722-623 |
| American Health Packaging | roflumilast | 60687-786 |
| Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
| Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
roflumilast drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Solco Healthcare US LLC | roflumilast | 43547-005 |
| Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
| Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
roflumilast drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | roflumilast | 31722-623 |
| American Health Packaging | roflumilast | 60687-786 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLENE CHLORIDE
roflumilast drug variants containing METHYLENE CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | roflumilast | 31722-623 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing METHYLENE CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
roflumilast drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
| Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
roflumilast drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | roflumilast | 31722-623 |
| American Health Packaging | roflumilast | 60687-786 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 188
roflumilast drug variants containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | roflumilast | 59651-275 |
| Aurobindo Pharma Limited | roflumilast | 59651-801 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 407
roflumilast drug variants containing POLOXAMER 407
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | roflumilast | 68382-969 |
| Zydus Lifesciences Limited | roflumilast | 70771-1674 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing POLOXAMER 407
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
roflumilast drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Novadoz Pharmaceuticals LLC | roflumilast | 72205-200 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| Camber Pharmaceuticals Inc | roflumilast | 31722-623 |
| Micro Labs Limited | roflumilast | 42571-259 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
roflumilast drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Camber Pharmaceuticals Inc | roflumilast | 31722-623 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
roflumilast drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| Camber Pharmaceuticals Inc | roflumilast | 31722-623 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPANE
roflumilast drug variants containing PROPANE
| Company | Ingredient | NDC |
|---|---|---|
| Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing PROPANE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
roflumilast drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
| Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
roflumilast drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | roflumilast | 31722-623 |
| American Health Packaging | roflumilast | 60687-786 |
| Zydus Pharmaceuticals USA Inc | roflumilast | 68382-969 |
| Zydus Lifesciences Limited | roflumilast | 70771-1674 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
roflumilast drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
| Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
roflumilast drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Solco Healthcare US LLC | roflumilast | 43547-005 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
roflumilast drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | roflumilast | 31722-623 |
| American Health Packaging | roflumilast | 60687-786 |
| Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
| Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
roflumilast drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
| Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Excipient focus: WHITE PETROLATUM
roflumilast drug variants containing WHITE PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Arcutis Biotherapeutics Inc | roflumilast | 80610-130 |
| Arcutis Biotherapeutics Inc | roflumilast | 80610-430 |
| >Company | >Ingredient | >NDC |
roflumilast drug variants not containing WHITE PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | roflumilast | 0310-0095 |
| Mylan Pharmaceuticals Inc | roflumilast | 0378-1905 |
| MAJOR PHARMACEUTICALS | roflumilast | 0904-7399 |
| Major Pharmaceuticals | roflumilast | 0904-7483 |
| Torrent Pharmaceuticals Limited | roflumilast | 13668-476 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
